Precision Oncology Solutions

What is CanCell?

Cancer is a complex group of diseases characterized by high heterogeneity at the cellular and molecular levels.

For this reason, oncology is increasingly shifting away from one-size-fits-all approaches toward data-driven and personalized evaluation strategies.

CanCell represents an infrastructure-based approach that aims to support more systematic and interpretable decision-making in oncology through methodologies such as molecular profiling and ex vivo drug response assessments.

How It Works

Molecular Profiling

Molecular analyses are performed on patient samples using predefined gene panels and biomarkers.
This process generates core data related to the biological characteristics of the tumor.

Ex Vivo Drug Response Testing

Data Analysis & Integration

Reporting

Using viable cells obtained from patient samples, cellular responses to anticancer drugs and drug combinations are evaluated under controlled ex vivo conditions.

Results from molecular profiling and ex vivo drug testing are integrated to perform comparative and cross-referenced analyses.

Outputs are presented in structured, standardized report formats, enabling clear interpretation and systematic evaluation.

Areas of Use

Clinical Oncology Studies

Provides a supportive infrastructure for evaluating personalized treatment strategies based on molecular and functional data.

Research Collaborations

Contributes to the generation of structured and comparable datasets for prospective and retrospective studies, including biomarker validation workflows.

Drug Discovery & Development

Supports early-stage drug candidate selection, hypothesis generation, and evaluation processes through ex vivo response data.

For more detailed information on the CanCell approach and the field of precision oncology, please visit the CanCell website.

What can you contact us for?

• Information about all brands, products and technology platforms developed within Tekgen

• Systems under productization, including technical approaches and development roadmaps

• R&D, research and technology-driven collaboration opportunities

• Corporate, strategic and commercial partnerships

• General corporate inquiries

Submit a Request

Informational Notice

The information provided on this page is intended solely for general informational purposes regarding approaches used in the field of precision oncology. The content presented here does not constitute medical diagnosis, treatment planning, or clinical guidance.

All clinical decisions and applications remain the responsibility of the relevant healthcare professionals and are carried out based on their independent evaluation. The appropriate approach for each patient must be determined according to individual conditions and professional judgment.

Those seeking further information on precision oncology approaches and data-driven evaluation processes may contact us according to their specific needs.